On February 15 this year. new Summary of Product Characteristics for COMIRNATY has been approved.
- Comirnates, 30 micrograms/dose, concentrate for dispersion for injection (with purple cap) and
- Comirnates, 10 micrograms/dose, concentrate for dispersion for injection (with orange cap).
The changes ...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at english@medexpress.pl.
If you already have an account, please log in